EMILY KAUFMAN: Open Payments
NPI 1306600887 · INMAN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Novo Nordisk Inc | 3 | $42 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: Rybelsus, INSPIRE, Dexcom G6 Transmitter, VRAYLAR, JARDIANCE, FARXIGA, GEMTESA, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
